speaker-photo

Olaleken O. Oluwole 🇺🇸

Specializes in treating hematological malignancies using stem cell transplantation and cellular therapy. Founded the VICC cellular therapy research program and led its early institutional expansion. Work focuses on advancing cell therapy as a comprehensive resource for malignant and non-malignant disorders.
9:45 AM - 10:05 AM

Day 2 | Hematology Track

Kite Pharma Satellite Symposium:

From Bench to Bedside:Yescartas Real -World evidence and the path toward cure in aggressive lymphoma

10:05 AM - 10:25 AM

Day 2 | Hematology Track

DLBLC molecular subtypes, are we ready for individualized treatments?

5:35 PM - 5:55 PM

Day 2 | Hematology Track

Follicular lymphoma